Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?
Catherine De MagnéeLouise BrunéeRoberto TambucciAurore PireIsabelle ScheersEtienne M SokalPamela BaldinFrancis ZechStéphane EeckhoudtRaymond RedingXavier StephennePublished in: Children (Basel, Switzerland) (2021)
ABOi LDLT is a feasible option for pediatric end-stage liver disease but carries increased risks for the recipient, especially for children older than 1 year, even with a specific preparation protocol. C4d immunostaining may be a hallmark of acute humoral rejection in ABOi liver transplantation.